Taiwan has an attractive pharmaceutical market, aided by its close proximity to China, which is probably the world's most attractive emerging pharmaceutical market, says a new report from Business Monitor International.
Patented drugs account for over 60% of the total market's value - some are manufactured locally, but the majority are imported from Western Europe, the USA and Japan. The over-the-counter (OTC) sub-sector is under-developed due to widespread and generous Bureau Pof National Health Insurance (BNHI) reimbursement for patented products.
Headline expenditure projections:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze